Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

[1]  M. J. Chalmers,et al.  Combined top-down and bottom-up mass spectrometric approach to characterization of biomarkers for renal disease. , 2005, Analytical chemistry.

[2]  Harald Mischak,et al.  Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes , 2005, Electrophoresis.

[3]  Ming Xu,et al.  Using tree analysis pattern and SELDI-TOF-MS to discriminate transitional cell carcinoma of the bladder cancer from noncancer patients. , 2005, European urology.

[4]  Walter Kolch,et al.  Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: Towards new diagnostic and therapeutic approaches , 2005, Electrophoresis.

[5]  T. Veenstra,et al.  Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery , 2005, Expert review of proteomics.

[6]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[7]  D. Chan,et al.  Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. , 2005, Clinical chemistry.

[8]  S. Humphries,et al.  Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway , 2004, Journal of thrombosis and haemostasis : JTH.

[9]  Thorsten Kaiser,et al.  Proteomic analysis for the assessment of diabetic renal damage in humans. , 2004, Clinical science.

[10]  S. Daneshmand,et al.  New molecular markers for bladder cancer detection , 2004, Current opinion in urology.

[11]  M. Guan,et al.  Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient. , 2004, Clinical biochemistry.

[12]  K. Williamson,et al.  Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?) , 2004, Current opinion in urology.

[13]  A. Vlahou,et al.  Protein Profiling in Urine for the Diagnosis of Bladder Cancer , 2004 .

[14]  R. Millikan,et al.  Focus on bladder cancer. , 2004, Cancer cell.

[15]  A. Ganser,et al.  Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. , 2004, Blood.

[16]  Erika Check,et al.  Proteomics and cancer: Running before we can walk? , 2004, Nature.

[17]  H. Mischak,et al.  Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. , 2004, Kidney international.

[18]  P. Dey.  Urinary markers of bladder carcinoma. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[19]  W. Kolch,et al.  Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[20]  H. R. Bergen,et al.  Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry , 2004, Disease markers.

[21]  Thorsten Kaiser,et al.  Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids. , 2003, Journal of chromatography. A.

[22]  Frank Dieterle,et al.  Urinary nucleosides as potential tumor markers evaluated by learning vector quantization , 2003, Artif. Intell. Medicine.

[23]  Anderson Nl,et al.  Therapeutic potential of the plasma proteome. , 2003 .

[24]  Marije Deutekom,et al.  Tumor markers in the diagnosis of primary bladder cancer. A systematic review. , 2003, The Journal of urology.

[25]  Antonia Vlahou,et al.  Application of a novel protein chip mass spectrometry technology for the identification of bladder cancer-associated biomarkers. , 2003, Advances in experimental medicine and biology.

[26]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[27]  F. Gieseler,et al.  Thrombin as a survival factor for cancer cells: thrombin activation in malignant effusions in vivo and inhibition of idarubicin-induced cell death in vitro. , 2002, International journal of clinical pharmacology and therapeutics.

[28]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[29]  B. Konety,et al.  Urine based markers of urological malignancy. , 2002, The Journal of urology.

[30]  M. Samama,et al.  The Thrombophilic State in Cancer Patients , 2001, Acta Haematologica.

[31]  G. Wright,et al.  Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. , 2001, The American journal of pathology.

[32]  R. Wilensky,et al.  Prospective Study Correlating Fibrinopeptide A, Troponin I, Myoglobin, and Myosin Light Chain Levels With Early and Late Ischemic Events in Consecutive Patients Presenting to the Emergency Department With Chest Pain , 2000, Circulation.

[33]  D Haussler,et al.  Knowledge-based analysis of microarray gene expression data by using support vector machines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Sobin,et al.  TNM classification of malignant tumors, fifth edition (1997) , 1997, Cancer.

[35]  D. Tassinari,et al.  Usefulness of coagulation markers in staging of gastric cancer. , 1995, Cancer detection and prevention.